Hamel Associates, Inc. Novartis Ag Transaction History

Hamel Associates, Inc.

$308 Million
Q4 2024

A detailed history of Hamel Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hamel Associates, Inc. holds 8,680 shares of NVS stock, worth $946,554. This represents 0.27% of its overall portfolio holdings.

Number of Shares

8,680

Previous 8,680 -0.0%

Holding current value

$946,554

Previous $998,000 15.43%

% of portfolio

0.27%

Previous 0.31%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$106.13 - $120.89 $3,714 - $4,231	35 Added 0.4%	8,680 $998,000
Q1 2024 Apr 23, 2024	SELL	$95.27 - $108.47 $47,635 - $54,235	-500 Reduced 5.47%	8,645 $836,000
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $46,135 - $50,770	-500 Reduced 5.18%	9,145 $923,000
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $480 - $556	-6 Reduced 0.06%	9,645 $887,000
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $67,636 - $78,750	-840 Reduced 8.01%	9,651 $816,000
Q1 2022 May 06, 2022	SELL	$80.11 - $90.62 $304,257 - $344,174	-3,798 Reduced 26.58%	10,491 $921,000
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $2.12 Million - $2.35 Million	-26,650 Reduced 65.1%	14,289 $1.25 Million
Q3 2021 Nov 08, 2021	SELL	$81.78 - $95.14 $704,861 - $820,011	-8,619 Reduced 17.39%	40,939 $3.35 Million
Q2 2021 Aug 04, 2021	SELL	$85.24 - $94.15 $83,109 - $91,796	-975 Reduced 1.93%	49,558 $4.52 Million
Q1 2021 May 04, 2021	SELL	$83.5 - $98.47 $166,165 - $195,955	-1,990 Reduced 3.79%	50,533 $4.32 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $47,622 - $57,602	-610 Reduced 1.15%	52,523 $4.96 Million
Q3 2020 Nov 09, 2020	BUY	$82.14 - $91.0 $17,660 - $19,565	215 Added 0.41%	53,133 $4.62 Million
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $28,325 - $31,884	-350 Reduced 0.66%	52,918 $4.62 Million
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $20,494 - $28,712	290 Added 0.55%	53,268 $4.39 Million
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $55,080 - $62,276	-653 Reduced 1.22%	52,978 $5.02 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $21,385 - $23,565	-250 Reduced 0.46%	53,631 $4.66 Million
Q2 2019 Aug 05, 2019	SELL	$75.4 - $92.8 $32,422 - $39,904	-430 Reduced 0.79%	53,881 $4.92 Million
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $17,700 - $20,245	235 Added 0.43%	54,311 $5.22 Million
Q3 2018 Oct 25, 2018	BUY	$66.94 - $77.43 $92,042 - $106,466	1,375 Added 2.61%	54,076 $4.66 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $16,876 - $19,073	-260 Reduced 0.49%	52,701 $3.98 Million
Q1 2018 May 03, 2018	SELL	$70.39 - $84.15 $12,318 - $14,726	-175 Reduced 0.33%	52,961 $4.28 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $723 - $776	10 Added 0.02%	53,136 $4.46 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $29,656 - $30,908	-400 Reduced 0.75%	53,126 $4.56 Million
Q2 2017 Aug 11, 2017	BUY	N/A	53,526	53,526 $4.47 Million

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Account

Hamel Associates, Inc. Novartis Ag Transaction History